Hospitalization for Heart Failure and Death in New Users of SGLT2 Inhibitors in Patients With and Without Cardiovascular Disease: CVD-REAL Study

被引：0
|
作者：
Cavender, Matthew A.
Norhammar, Anna
Birkeland, Kare I.
Jorgensen, Marit Eika
Wilding, John P. H.
Khunti, Kamlesh
Fu, Alex Z.
Bodegard, Johan
Blak, Betina T.
Wittbrodt, Eric T.
Thuresson, Marcus
Fenici, Peter
Hammar, Niklas
Kosiborod, Mikhail N.
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
377-OR
引用
收藏
页码：A99 / A100
页数：2
相关论文
共 50 条
  • [1] Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVDREAL study
    Cavender, M. A.
    Norhammar, A.
    Birkeland, K. I.
    Jorgensen, M. E.
    Wilding, P.
    Khunti, K.
    Fu, A. Z.
    Bodegard, J.
    Blak, B.
    Wittbrodt, E. T.
    Thuresson, M.
    Fenici, P.
    Hammar, N.
    Kosiborod, M.
    DIABETOLOGIA, 2017, 60 : S41 - S41
  • [2] SGLT2 Inhibitors Reduce Heart Failure Hospitalization and Cardiovascular Death Clarity and Consistency
    Wiviott, Stephen D.
    Berg, David D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (25)
  • [3] SGLT-2 Inhibitors and Cardiovascular Risk An Analysis of CVD-REAL
    Cavender, Matthew A.
    Norhammar, Anna
    Birkeland, Kare I.
    Jorgensen, Marit Eika
    Wilding, John P.
    Khunti, Kamlesh
    Fu, Alex Z.
    Bodegard, Johan
    Blak, Betina T.
    Wittbrodt, Eric
    Thuresson, Marcus
    Fenici, Peter
    Hammar, Niklas
    Kosiborod, Mikhail
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (22) : 2497 - 2506
  • [4] Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study
    Kohsaka, Shun
    Lam, Carolyn S. P.
    Kim, Dae Jung
    Cavender, Matthew A.
    Norhammar, Anna
    Jorgensen, Marit E.
    Birkeland, Kare, I
    Holl, Reinhard W.
    Franch-Nadal, Josep
    Tangri, Navdeep
    Shaw, Jonathan E.
    Ilomaki, Jenni
    Karasik, Avraham
    Goh, Su-Yen
    Chiang, Chern-En
    Thuresson, Marcus
    Chen, Hungta
    Wittbrodt, Eric
    Bodegard, Johan
    Surmont, Filip
    Fenici, Peter
    Kosiborod, Mikhail
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (07): : 606 - 615
  • [5] Efficacy of SGLT2 inhibitors for the reduction of cardiovascular death and heart failure hospitalization among non-diabetic heart failure patients: a meta-analysis
    Leycano, D.
    Cruz, M. G.
    Ang, E. O.
    Tiongco, R. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 184 - 184
  • [6] Prevention of Heart Failure With SGLT-2 Inhibition Insights From CVD-REAL
    Farkouh, Michael E.
    Verma, Subodh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (22) : 2507 - 2510
  • [7] SGLT2 Inhibitors and Cardiovascular Outcomes: Do They Differ or There is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL Study
    Kyriakos, Georgios
    Quiles-Sanchez, Lourdes, V
    Garmpi, Anna
    Farmaki, Paraskevi
    Kyre, Konstantina
    Savvanis, Spyridon
    Antoniou, Vasileios K.
    Memi, Eleni
    CURRENT CARDIOLOGY REVIEWS, 2020, 16 (04) : 258 - 265
  • [8] Total events of hospitalisation for heart failure in new users of SGLT-2 inhibitors: real world data from 5 countries and more than 298,000 patients: the CVD-REAL study
    Kosiborod, M.
    Cavender, M. A.
    Fu, A. Z.
    Norhammar, A.
    Birkeland, K. I.
    Jorgensen, M.
    Holl, R. W.
    Hammar, N.
    Wittbrodt, E. T.
    Bodegard, J.
    Scheerer, M.
    Thuresson, M.
    Fenici, P.
    DIABETOLOGIA, 2017, 60 : S41 - S42
  • [9] Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
    Edoardo G. Gronda
    Emilio Vanoli
    Massimo Iacoviello
    Stefano Urbinati
    Pasquale Caldarola
    Furio Colivicchi
    Domenico Gabrielli
    Heart Failure Reviews, 2023, 28 : 723 - 732
  • [10] Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
    Gronda, Edoardo G.
    Vanoli, Emilio
    Iacoviello, Massimo
    Urbinati, Stefano
    Caldarola, Pasquale
    Colivicchi, Furio
    Gabrielli, Domenico
    HEART FAILURE REVIEWS, 2023, 28 (03) : 723 - 732
12345